Hcw Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development Loan
Amount Raised
$26.3 Million
Round Type
Debt Financing
MiramarBiotechnologyHealth CareTherapeuticsBiopharmaDescription
HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, entered into a $26.25 million development line of credit agreement on April 21, 2023. This five-year, non-amortizing loan, collateralized with real estate assets, provides project financing for the buildout of the Company’s new headquarters and manufacturing facility. Funds formerly earmarked for this purpose will be redeployed for clinical development, including multiple Phase 2 clinical trials in cancer indications to continue to evaluate HCW9218, the Company’s injectable, bifunctional fusion protein molecule for reduction of senescence; and a Phase 1b clinical study in an autoimmune disease to evaluate HCW9302, the Company’s injectable, IL-2-based fusion compound.
Quick answer
HCW Biologics raised $26.3 Million in a Debt Financing round, dated April 27, 2023. HCW Biologics is based in Miramar, Florida, United States.
- How much did HCW Biologics raise?
- HCW Biologics raised $26.3 Million in a Debt Financing round on April 27, 2023.
- What does HCW Biologics do?
- HCW Biologics is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between chronic, low-grade inflammation, and..
- Where is HCW Biologics based and how big is it?
- HCW Biologics is based in Miramar, Florida, United States. Fundz records about 35 employees.
- Who are the decision-makers at HCW Biologics?
- Fundz holds 1 contact at HCW Biologics, including the Executive Officer, Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biopharma around the same time
Companies in the same sectors as HCW Biologics that raised within 45 days of this round, from Fundz verified event records.
- Alkeus Pharmaceuticals raised $150M (Series B) on June 5, 2023.
- Renibus Therapeutics raised $64M on May 25, 2023.
- Decoy Therapeutics Inc. raised $6M on May 11, 2023.
- Mezzion Pharma raised $40M (Funding Round) on April 25, 2023.
- DiaMedica Therapeutics raised $750K (Seed) on April 10, 2023.
- Milestone Pharmaceuticals raised $125M on March 28, 2023.
Who to call at HCW Biologics, and when
A new round usually means HCW Biologics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day HCW Biologics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at HCW Biologics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at HCW Biologics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment HCW Biologics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
HCW Biologics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.